Adaptin Bio (APTN) Non Operating Interest Expenses (2024 - 2026)

Adaptin Bio has disclosed Non Operating Interest Expenses across 3 years of filings, most recently posting $4696.0 for Q2 2026.

• In Q2 2026, Non Operating Interest Expenses changed N/A year-over-year to $4696.0; the TTM figure through Jun 2026 stood at $6639.0 (down 97.96% YoY), while the FY2025 annual figure was $72659.0, down 78.7% from the prior year.
• Non Operating Interest Expenses came in at $4696.0 for Q2 2026 at Adaptin Bio, up from $1943.0 in the prior quarter.
• In the past five years, Non Operating Interest Expenses ranged from a high of $145887.0 in Q4 2024 to a low of $1943.0 in Q1 2026.
• Average Non Operating Interest Expenses over 3 years is $60049.4, with a median of $49045.0 recorded in 2024.
• Year-over-year, Non Operating Interest Expenses soared 83.65% in 2025 and slumped 97.33% in 2026.
• Over 3 years, Non Operating Interest Expenses stood at $145887.0 in 2024, then plunged by 50.2% to $72659.0 in 2025, then tumbled by 93.54% to $4696.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $4696.0 in Q2 2026, $1943.0 in Q1 2026, and $72659.0 in Q1 2025.